In the realm of biochemical research and molecular design, the TAT-HA2 peptide sequence represent The name of the Tat pathway relates to a highly conserved twin-arginine leader motif (S/TRRXFLK) which is found in the N terminal Signal peptide of the s a sophisticated fusion architecture. As someone who has long followed advancements in peptide-based delivery agents TAT-HA2 Fusion Peptide is a transactivator of transcription and hemaglutanin for endosomal release. TAT-HA2 Fusion Peptide enhances cellular uptake of , I find the integration of cell-penetrating capabilities with endosomal escape m Cell-penetrating Peptides echanisms to be one of the most fascinating areas of study. This article provides an in-depth look at the structural components and functional rationale behind this chimeric molecule.
The Structural Composition of TAT-HA2
The TAT-HA2 Fusion Peptide is a bifunctional construct designed to facilitate the transport of macromolecules. by YJ Lee · 2011 · Cited by 59 — We investigate the biophysical and cellular properties of the glutamate-rich HA2 analog E5 fused to the model protein TAT-mCherry. RESULTS. E5-TAT-mCherry By combining two distinct biological motifs, it addresses the common challenge of intracellular delivery.
1. The TAT Component
The TAT portion is a cell-penetrating peptide (CPP) derived from the transactivato Cell-penetrating peptide sequence and modification r of transcription of the human immunodeficiency virus. Specifically, the Tat peptide (often associated with the sequence YGRKKRRQRRR or similar variants) is known for its cationic nature. This allows it to interact with cellular membranes, facilitating the initial uptake of the peptide into the cell, typically via endocytosis.
2. The HA2 Component
To overcome the bottleneck of endosomal entrapment, the design incorporates amino acids 1 to 20 of influenza A virus hemagglutinin protein (HA2). This HA2 peptide is a well-documented pH-responsive, fusogenic element. In the acidic environment of the endosome, this peptide HA2 undergoes a conformational change from a random coil to an alpha-helical structure, which disrupts the endosomal membrane and allows the cargo to reach the cytosol.
Technical Specifications and Characteristics
When analyzing the TAT-HA2 Fusion Peptide, researchers often focus on its specific sequence and physical properties:
* Molecular Composition: The fusion combines the cationic TAT sequence with the hydrophobic/amphiphilic HA2 domain.
* Mechanism: While the TAT-HA has been shown to deliver proteins into cells, the synergy between these two parts is what makes it a highly efficient tool.
* Variations: Beyond the standard fusion, researchers have explored modifications such as dTAT-HA2, which is a transducible, pH-sensitive version designed to enhance the escape of proteins like TAT-Cre from macropinosomes.
* Other Derivatives: Related structures, such as Peptide A5K (INF7-A5K-TAT), demonstrate how the HA2-TAT fusion scaffold can be further optimized for binding to complex cargoes like CRISPR ribonucleoproteins.
Integration of Functionality
The design of this sequence TAT is not arbitrary; it is a calculated approach to intracellular trafficking. The TAT (47-57) peptide provides the "ticket" for cellular entry, while the HA2 domain provides the "key" to exit the endosome.
For those interested in the biophysics of these molecules, it is important to note that the sequence and the order of the amino acids are critical. Even minor alterations—such as replacing a cysteine with a serine—can significantly Peptide A5K (INF7-A5K-TAT) is an amphiphilic peptide derived from the HA2-TAT fusion scaffold. Peptide A5K can non-covalently bind to CRISPR ribonucleoproteins impact the biological activity, as seen in various comparative studies of chimeric peptides.
Why This Matters in Research
The TAT-HA2 Fusion Peptide serves as a foundational model for researchers studying membrane translocation. By utilizing the TAT peptide for uptake and the HA2 peptide for membrane fusion, scientists can investigate the limitations of delivery vectors. Whether you are looking at the TAT-HA2 Fusion Peptide from a structural biology perspective or as a delivery agent, the precision of its design—combining the transactivator of transcription (TAT) of human immunodeficiency virus with the fusogenic properties of hemagglutinin—remains a gold standard in the field.
As someone observing these developments, it is clear that the refi TAT-HA2 Fusion Peptide | CAS NO.:923954-79-4 nement of these short sequences continues to drive innovation in how we approach the delivery of complex molecules, ensuring that the peptide sequence remains as effective as possible for specific investigative goals.